13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC
SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 84 holding rows worth $172,124,000.
- Accession
- 0001420506-21-000331
- Filer
- CIK 1816307
- Filed
- 2021-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 85 entries on the cover page, a total value of $172,124,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $172,124,000 with VALUE read as thousands by filing date, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSILVERARC CAPITAL, LLC028-20993
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VERICEL CORP | 92346J108 | COM | 281,346 | $8,688,000 | thousands by filing date | |
| BIOGEN INC | 09062X903 | CALL | 30,000 | $7,346,000 | thousands by filing date | call |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 200,000 | $6,360,000 | thousands by filing date | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 351,616 | $6,301,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 175,000 | $5,826,000 | thousands by filing date | |
| AMRYT PHARMA LTD - SPNR ADR | 03217L106 | COMMON EQUITY | 402,556 | $5,700,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 227,388 | $5,009,000 | thousands by filing date | |
| ARVINAS INC | 04335A105 | COM | 55,000 | $4,671,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 217,203 | $4,650,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 100,000 | $4,619,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 20,000 | $4,393,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 530,000 | $4,341,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 100,000 | $4,271,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 136,000 | $4,206,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 185,000 | $4,016,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 600,000 | $3,870,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 322,917 | $3,852,000 | thousands by filing date | |
| CELLECTAR BIOSCIENCES INC | 15117F500 | COM PAR | 1,772,848 | $3,688,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 53,766 | $3,329,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 90,000 | $2,939,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 17,556 | $2,928,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 406,665 | $2,847,000 | thousands by filing date | |
| EVOGENE LTD | M4119S104 | SHS | 600,000 | $2,820,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 235,066 | $2,640,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 215,071 | $2,445,000 | thousands by filing date | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 18,825 | $2,426,000 | thousands by filing date | |
| VERASTEM INC | 92337C104 | COM | 1,135,753 | $2,419,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 400,000 | $2,328,000 | thousands by filing date | |
| Renalytix PLC | 75973T101 | ADS | 141,253 | $2,260,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 38,620 | $2,204,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 30,000 | $2,195,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 135,000 | $2,164,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 16,131 | $1,966,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 440,955 | $1,909,000 | thousands by filing date | |
| COMPUGEN LTD | M25722105 | ORD | 150,550 | $1,823,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 51,433 | $1,726,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 263,951 | $1,708,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 110,000 | $1,618,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 20,000 | $1,537,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 30,834 | $1,457,000 | thousands by filing date | |
| NEXTCURE INC | 65343E108 | COM | 130,000 | $1,417,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 16,500 | $1,414,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 80,282 | $1,407,000 | thousands by filing date | |
| SEAGEN INC | 81181C104 | COM | 7,509 | $1,315,000 | thousands by filing date | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 25,000 | $1,213,000 | thousands by filing date | |
| SURFACE ONCOLOGY INC | 86877M209 | COM | 130,000 | $1,201,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 5,000 | $1,182,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 44,007 | $1,072,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 241,756 | $1,003,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 280,000 | $1,002,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 15,000 | $922,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 35,179 | $908,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 130,043 | $899,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 110,000 | $820,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 5,364 | $814,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 5,000 | $781,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 120,000 | $776,000 | thousands by filing date | |
| CALITHERA BIOSCIENCES INC | 13089P901 | COM | 150,000 | $737,000 | thousands by filing date | call |
| BIOGEN INC COM | 09062X103 | Stock | 3,000 | $735,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 25,200 | $726,000 | thousands by filing date | |
| ACTINIUM PHARMACEUTICALS | 00507W206 | COM | 90,000 | $702,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 102,198 | $693,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 30,000 | $667,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 5,000 | $662,000 | thousands by filing date | |
| SOLENO THERAPEUTIVS, INC. | 834203200 | COMM | 322,798 | $623,000 | thousands by filing date | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 275,000 | $619,000 | thousands by filing date | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 25,000 | $613,000 | thousands by filing date | |
| GAMIDA CELL LTD | M47364100 | SHS | 70,852 | $594,000 | thousands by filing date | |
| VYNE THERAPEUTICS INC | 92941V100 | COM NEW | 349,624 | $552,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 10,000 | $548,000 | thousands by filing date | |
| THERAPEUTICS ACQUISITION COR | 88339T103 | COM CL A | 39,009 | $543,000 | thousands by filing date | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 10,000 | $519,000 | thousands by filing date | |
| MEDICENNA THERAPEUTICS F | 58490H107 | FOREIGN CANADIAN | 107,536 | $503,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 10,000 | $464,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 20,910 | $422,000 | thousands by filing date | |
| APTINYX INC | 03836N103 | COM | 107,536 | $372,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 10,763 | $286,000 | thousands by filing date | |
| COMPUGEN LTD | M25722905 | ORD | 20,000 | $242,000 | thousands by filing date | call |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 8,505 | $239,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 16,209 | $190,000 | thousands by filing date | |
| BIOMX INC | 09090D103 | COM | 13,759 | $88,000 | thousands by filing date | |
| CALITHERA BIOSCIENCES INC COM NEW | 13089P101 | Stock | 15,000 | $74,000 | thousands by filing date | |
| CHARDAN HEALTHCR ACQSTN 2 CO | 15957T115 | *W EXP 03/05/202 | 98,756 | $49,000 | thousands by filing date | |
| BIONANO GENOMICS INC | 09075F115 | *W EXP 08/21/202 | 10,000 | $21,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-21-000331 | this filing | 2021-02-16 | acceptance time not in the bulk data set |